Company Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.
The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.
It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists.
The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally.
STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
| Country | United States |
| Founded | 1982 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 1,157 |
| CEO | Stephen Farrell |
Contact Details
Address: 25510 Commercentre Drive Lake Forest, California 92630 United States | |
| Phone | 626 303 7902 |
| Website | staar.com |
Stock Details
| Ticker Symbol | STAA |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000718937 |
| CUSIP Number | 852312305 |
| ISIN Number | US8523123052 |
| Employer ID | 95-3797439 |
| SIC Code | 3851 |
Key Executives
| Name | Position |
|---|---|
| Deborah J. Andrews | Interim Co-Chief Executive Officer and Chief Financial Officer |
| Warren Foust | Interim Co-Chief Executive Officer, President and Chief Operating Officer |
| Dr. Magda Michna Ph.D. | Chief Development Officer |
| Nathaniel B. Sisitsky Esq. | Consultant |
| Nancy Sabin | Chief Marketing Officer |
| Dr. Scott D. Barnes M.D. | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 5, 2026 | 8-K | Current Report |
| Feb 2, 2026 | 8-K | Current Report |
| Jan 16, 2026 | SCHEDULE 13D/A | Filing |
| Jan 16, 2026 | SCHEDULE 13D/A | Filing |
| Jan 16, 2026 | 8-K | Current Report |
| Jan 15, 2026 | 8-K | Current Report |
| Jan 8, 2026 | SCHEDULE 13D/A | Filing |
| Jan 6, 2026 | 8-K | Current Report |
| Jan 6, 2026 | 8-K | Current Report |
| Dec 19, 2025 | DFAN14A | Filing |